PUNE, India, March 18, 2016 /PRNewswire/ --
According to a new market research report "Polymerase Chain Reaction Usage Pattern and Replacement Trends, End User Analysis, Pricing Analysis, Comparative Analysis, Competitive Landscape Comparative Analysis and End User Preference Study", published by MarketsandMarkets, analyzes and studies the PCR technology in terms of pricing, replacement trends, competitors' portfolio analysis, and selection criteria for adopting PCR instruments from an end-user perspective.
Browse 14 Figures spread through 65 Slides and in-depth TOC on "Polymerase Chain Reaction"http://www.marketsandmarkets.com/Market-Reports/polymerase-chain-reaction-249309546.html
Early buyers will receive 10% customization on this report.
The overall market for PCR technology market is expected to grow rapidly owing to the expansion of its application areas and increased accuracy and precision. Furthermore, specific technology segments of the PCR market, such as dPCR (real-time PCR) and qPCR (digital PCR), are witnessing higher market growth owing to their benefits such as real-time process monitoring, low reagent consumption, automation of workflow, and greater reproducibility and precision. The real-time PCR segment commanded the largest share of the global PCR market in 2014, due to several factors including technological advancements, increasing use of qPCR in research and medical diagnostics, growing use of robotics for lab automation, and expansion of installation base.
The growing geriatric population, coupled with an increasing prevalence e of chronic diseases, and technological advancements in the field of life science are the key factors driving the growth of qPCR and dPCR market. The rising incidence of infectious diseases and genetic disorders and increased public-private investments, funds, and grants for PCR-based research are further assisting the market growth.
However, the high cost of dPCR instruments and technological limitations associated with qPCR and dPCR are the key factors limiting the growth of this market. In addition, the implementation of the Minimum Information for the Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines is a key challenge faced by industry players in this market.
The study provides granular information regarding pricing of PCR instruments with breakdown into various cost components. These cost components include machine cost, accessories cost, training cost, services and software cost, and maintenance cost, among others. The report also provides insights on replacement trends and end-user preferences for PCR systems.
Speak to our Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=249309546
The report also contains detailed analysis of end users of PCR instruments and their preferences. The PCR instruments end-user market can be divided into four distinct segments, reference laboratories, research laboratories/academic institutes/hospitals, medium-sized laboratories, and others (clinical research organizations and forensic laboratories). Reference laboratories commanded the largest share of PCR instrument market owing to increased test volume of infectious diseases and various types of cancers.
The research findings cited in the report encapsulates the important selection criteria for PCR machines from an end-user point of view. It analyses each end-user segment and importance given to the particular criteria while selecting a PCR machine. Some of the important criteria for selection of PCR systems include consistent quality of data, sensitivity, services and support, high-throughput ability, multiplexing capacity, ease of use, and price and brand of instrument.
Browse Related Reports:
Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020
Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets